BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28864048)

  • 1. [Who can be dismissed in rectal cancer management?].
    Rouanet P
    Cancer Radiother; 2017 Oct; 21(6-7):536-538. PubMed ID: 28864048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy.
    Battersby NJ; Moran B; Yu S; Tekkis P; Brown G
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):703-19. PubMed ID: 24954622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the neoadjuvant treatment of rectal cancer: balancing the risk of recurrence and quality of life.
    Glynne-Jones R; Harrison M; Hughes R
    Cancer Radiother; 2013 Nov; 17(7):675-85. PubMed ID: 24183502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Organ preserving strategies for rectal cancer treatment].
    Vendrely V; Denost Q; Amestoy F; Célérier B; Smith D; Rullier A; Rullier É
    Cancer Radiother; 2015 Oct; 19(6-7):404-9. PubMed ID: 26278990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of rectal cancer.
    Costa-Silva L; Brown G
    Magn Reson Imaging Clin N Am; 2013 May; 21(2):385-408. PubMed ID: 23642559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailored rectal cancer treatment--a time for implementing contemporary prognostic factors?
    Wibe A; Law WL; Fazio V; Delaney CP
    Colorectal Dis; 2013 Nov; 15(11):1333-42. PubMed ID: 23758978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limits of endorectal ultrasound in tailoring treatment of patients with rectal cancer.
    Restivo A; Zorcolo L; Marongiu L; Scintu F; Casula G
    Dig Surg; 2015; 32(2):129-34. PubMed ID: 25791387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal cancer: An evidence-based update for primary care providers.
    Gaertner WB; Kwaan MR; Madoff RD; Melton GB
    World J Gastroenterol; 2015 Jul; 21(25):7659-71. PubMed ID: 26167068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multidisciplinary approach to the treatment of rectal cancer: 2015 update.
    Onyeuku NE; Ayala-Peacock DN; Russo SM; Blackstock AW
    Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):507-17. PubMed ID: 25431898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical issues in the evolving management of rectal cancer.
    Mohiuddin M; Ahmed MM
    Semin Oncol; 1997 Dec; 24(6):732-44. PubMed ID: 9422268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature.
    Chadi SA; Berho M; Wexner SD
    Langenbecks Arch Surg; 2015 Aug; 400(6):661-73. PubMed ID: 26250144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-Staging Following Long-Course Chemoradiotherapy For Rectal Cancer: Does It Influence Management?
    McBrearty A; McCallion K; Moorehead RJ; McAllister I; Mulholland K; Gilliland R; Campbell WJ
    Ulster Med J; 2016 Sep; 85(3):178-181. PubMed ID: 27698520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the "DISTANCE"?
    Nougaret S; Reinhold C; Mikhael HW; Rouanet P; Bibeau F; Brown G
    Radiology; 2013 Aug; 268(2):330-44. PubMed ID: 23882096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting concepts in rectal cancer management: a review of contemporary primary rectal cancer treatment strategies.
    Kosinski L; Habr-Gama A; Ludwig K; Perez R
    CA Cancer J Clin; 2012; 62(3):173-202. PubMed ID: 22488575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avoiding radical surgery improves early survival in elderly patients with rectal cancer, demonstrating complete clinical response after neoadjuvant therapy: results of a decision-analytic model.
    Smith FM; Rao C; Oliva Perez R; Bujko K; Athanasiou T; Habr-Gama A; Faiz O
    Dis Colon Rectum; 2015 Feb; 58(2):159-71. PubMed ID: 25585073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical research for rectal carcinoma: State of the art and objectives].
    Maingon P; Simon JM; Canova CH; Troussier I; Besson N; Caillot É; Huguet F
    Cancer Radiother; 2017 Oct; 21(6-7):533-535. PubMed ID: 28890092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of MRI in determining the therapy of rectal cancer].
    Jederán E; Mátrai Z; Tóth L; Lövey J; Láng I; Hitre E; Naszádos G; Gõdény M
    Magy Onkol; 2012 Sep; 56(3):179-86. PubMed ID: 23008826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic ultrasound: current role and future perspectives in managing rectal cancer patients.
    Cârţână ET; Pârvu D; Săftoiu A
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):407-13. PubMed ID: 22187707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra low resection versus abdomino-perineal excision in low rectal cancer.
    Holm T
    Recent Results Cancer Res; 2014; 203():57-67. PubMed ID: 25103000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
    Carpinetti P; Donnard E; Bettoni F; Asprino P; Koyama F; Rozanski A; Sabbaga J; Habr-Gama A; Parmigiani RB; Galante PA; Perez RO; Camargo AA
    Oncotarget; 2015 Nov; 6(35):38360-71. PubMed ID: 26451609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.